Bioanalytical automatlon: history and future plans

Bioanalysis is determining the concentration of drugs and metabolites in biological fluids (i.e. plasma and urine). During the past 15 years tremendous advances in bioanalysis, for example HPLC, auto injectors, data collection systems and robotics has enabled the productivity of the bioanalyst to in...

Descripción completa

Detalles Bibliográficos
Autor principal: Farmen, Raymond H.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2548046/
https://www.ncbi.nlm.nih.gov/pubmed/18924997
http://dx.doi.org/10.1155/S1463924694000118
_version_ 1782159389738663936
author Farmen, Raymond H.
author_facet Farmen, Raymond H.
author_sort Farmen, Raymond H.
collection PubMed
description Bioanalysis is determining the concentration of drugs and metabolites in biological fluids (i.e. plasma and urine). During the past 15 years tremendous advances in bioanalysis, for example HPLC, auto injectors, data collection systems and robotics has enabled the productivity of the bioanalyst to increase but it still requires considerable manual intervention. This paper describes the rationale, the justification and the plans Bristol-Myers Squibb has to completely automate the entire bioanalytical process.
format Text
id pubmed-2548046
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-25480462008-10-16 Bioanalytical automatlon: history and future plans Farmen, Raymond H. J Automat Chem Research Article Bioanalysis is determining the concentration of drugs and metabolites in biological fluids (i.e. plasma and urine). During the past 15 years tremendous advances in bioanalysis, for example HPLC, auto injectors, data collection systems and robotics has enabled the productivity of the bioanalyst to increase but it still requires considerable manual intervention. This paper describes the rationale, the justification and the plans Bristol-Myers Squibb has to completely automate the entire bioanalytical process. Hindawi Publishing Corporation 1994 /pmc/articles/PMC2548046/ /pubmed/18924997 http://dx.doi.org/10.1155/S1463924694000118 Text en Copyright © 1994 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Farmen, Raymond H.
Bioanalytical automatlon: history and future plans
title Bioanalytical automatlon: history and future plans
title_full Bioanalytical automatlon: history and future plans
title_fullStr Bioanalytical automatlon: history and future plans
title_full_unstemmed Bioanalytical automatlon: history and future plans
title_short Bioanalytical automatlon: history and future plans
title_sort bioanalytical automatlon: history and future plans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2548046/
https://www.ncbi.nlm.nih.gov/pubmed/18924997
http://dx.doi.org/10.1155/S1463924694000118
work_keys_str_mv AT farmenraymondh bioanalyticalautomatlonhistoryandfutureplans

Ejemplares similares